Aliri (formerly ImaBiotech and Pyxant Labs) is committed to solving industry challenges by bringing innovative bioanalytical and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise.

Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalytical lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.

The company combines expertise in biologics, oligonucleotides and small molecules bioanalysis with a large set of Mass Spectrometers and very unique imaging capabilities to measure distribution and concentrations of every type of drugs and biomarkers (proteins, oligos and small molecules) at cellular level in tissue. The combination of the different capabilities allows to measure efficacy and toxicity with high degree of precision, from drug discovery to help to select the right candidate and from clinical stages to better design and advance your molecules to the marker.